Antidepressants do not improve event-free survival in patients with heart failure when depressive symptoms remain

Heart and Lung: Journal of Acute and Critical Care

Volumn 42, Issue 2, 2013, Pages 85-91

  Chung, Misook L ^a   Dekker, Rebecca L ^a   Lennie, Terry A ^a   Moser, Debra K ^a  

^a UNIVERSITY OF KENTUCKY COLLEGE OF NURSING   (United States)

Author keywords

Antidepressants; Depressive symptoms; Heart failure; Mortality

Indexed keywords

AMFEBUTAMONE; AMITRIPTYLINE; ANTIDEPRESSANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOXEPIN; DULOXETINE; FLUVOXAMINE; MIRTAZAPINE; NORADRENALIN UPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TETRACYCLIC ANTIDEPRESSANT AGENT; TRAZODONE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; ARTICLE; BODY MASS; DEATH; DEPRESSION; DIABETES MELLITUS; DISEASE REGISTRY; EVENT FREE SURVIVAL; FEMALE; FOLLOW UP; HEART FAILURE; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; OUTCOME ASSESSMENT; PATIENT HEALTH QUESTIONNAIRE 9; PRIORITY JOURNAL; QUESTIONNAIRE; RISK;

AGED; ANTIDEPRESSIVE AGENTS; DEPRESSION; DISEASE-FREE SURVIVAL; FEMALE; HEART FAILURE; HOSPITALIZATION; HUMANS; MALE; MIDDLE AGED; MORTALITY; OUTCOME AND PROCESS ASSESSMENT (HEALTH CARE); PROGNOSIS; REGISTRIES; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME;

EID: 84875263688     PISSN: 01479563     EISSN: 15273288     Source Type: Journal    
DOI: 10.1016/j.hrtlng.2012.12.003     Document Type: Article

References (39)

1. Rutledge T., Reis V.A., Linke S.E., Greenberg B.H., Mills P.J. Depression in heart failure a meta-analytic review of prevalence, intervention effects, and associations with clinical outcomes. J Am Coll Cardiol 2006, 48:1527-1537.
2. Jiang W., Alexander J., Christopher E., et al. Relationship of depression to increased risk of mortality and rehospitalization in patients with congestive heart failure. Arch Intern Med 2001, 161:1849-1856.
3. Sherwood A., Blumenthal J.A., Trivedi R., et al. Relationship of depression to death or hospitalization in patients with heart failure. Arch Intern Med 2007, 167:367-373.
4. Vaccarino V., Kasl S.V., Abramson J., Krumholz H.M. Depressive symptoms and risk of functional decline and death in patients with heart failure. J Am Coll Cardiol 2001, 38:199-205.
5. Freedland K.E., Carney R.M., Krone R.J., et al. Psychological factors in silent myocardial ischemia. Psychosom Med 1991, 53:13-24.
6. Koenig H.G. Depression in hospitalized older patients with congestive heart failure. Gen Hosp Psychiatry 1998, 20:29-43.
7. Lichtman J.H., Bigger J.T., Blumenthal J.A., et al. Depression and coronary heart disease: recommendations for screening, referral, and treatment: a science advisory from the American Heart Association Prevention Committee of the Council on Cardiovascular Nursing, Council on Clinical Cardiology, Council on Epidemiology and Prevention, and Interdisciplinary Council on Quality of Care and Outcomes Research: endorsed by the American Psychiatric Association. Circulation 2008, 118:1768-1775.
8. Glassman A.H., Bigger J.T., Gaffney M., Shapiro P.A., Swenson J.R. Onset of major depression associated with acute coronary syndromes: relationship of onset, major depressive disorder history, and episode severity to sertraline benefit. Arch Gen Psychiatry 2006, 63:283-288.
9. Glassman A.H., O'Connor C.M., Califf R.M., et al. Sertraline treatment of major depression in patients with acute mi or unstable angina. JAMA 2002, 288:701-709.
10. O'Connor C.M., Jiang W., Kuchibhatla M., et al. Safety and efficacy of sertraline for depression in patients with heart failure: results of the SADHART-CHF (sertraline against depression and heart disease in chronic heart failure) trial. J Am Coll Cardiol 2010, 56:692-699.
11. Gottlieb S.S., Kop W.J., Thomas S.A., et al. A double-blind placebo-controlled pilot study of controlled-release paroxetine on depression and quality of life in chronic heart failure. Am Heart J 2007, 153:868-873.
12. Lesperance F., Frasure-Smith N., Laliberte M.A., et al. An open-label study of nefazodone treatment of major depression in patients with congestive heart failure. Can J Psychiatry 2003, 48:695-701.
13. Artinian N.T., Artinian C.G., Saunders M.M. Identifying and treating depression in patients with heart failure. J Cardiovasc Nurs 2004, 19:S47-S56.
14. O'Connor C.M., Jiang W., Kuchibhatla M., et al. Antidepressant use, depression, and survival in patients with heart failure. Arch Intern Med 2008, 168:2232-2237.
15. Tousoulis D., Antoniades C., Drolias A., et al. Selective serotonin reuptake inhibitors modify the effect of beta-blockers on long-term survival of patients with end-stage heart failure and major depression. J Card Fail 2008, 14:456-464.
16. Summers K.M., Martin K.E., Watson K. Impact and clinical management of depression in patients with coronary artery disease. Pharmacotherapy 2010, 30:304-322.
17. Berkman L.F., Blumenthal J., Burg M., et al. Effects of treating depression and low perceived social support on clinical events after myocardial infarction: the enhancing recovery in coronary heart disease patients (ENRICHD) randomized trial. JAMA 2003, 289:3106-3116.
18. Glassman A.H., Bigger J.T., Gaffney M. Psychiatric characteristics associated with long-term mortality among 361 patients having an acute coronary syndrome and major depression: seven-year follow-up of SADHART participants. Arch Gen Psychiatry 2009, 66:1022-1029.
19. Riegel B., Moser D.K., Glaser D., et al. The Minnesota living with heart failure questionnaire: sensitivity to differences and responsiveness to intervention intensity in a clinical population. Nurs Res 2002, 51:209-218.
20. Riegel B., Moser D.K., Rayens M.K., et al. Ethnic differences in quality of life in persons with heart failure. J Card Fail 2008, 14:41-47.
21. Lee K.S., Lennie T.A., Heo S., Moser D.K. Association of physical versus affective depressive symptoms with cardiac event-free survival in patients with heart failure. Psychosom Med 2012, 74:452-458.
22. Chung M.L., Lennie T.A., Dekker R.L., Wu J.R., Moser D.K. Depressive symptoms and poor social support have a synergistic effect on event-free survival in patients with heart failure. Heart Lung 2011, 40:492-501.
23. Song E.K., Moser D.K., Frazier S.K., Heo S., Chung M.L., Lennie T.A. Depressive symptoms affect the relationship of N-terminal pro B-type natriuretic peptide to cardiac event-free survival in patients with heart failure. J Card Fail 2010, 16:572-578.
24. Kroenke K., Spitzer R.L., Williams J.B. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med 2001, 16:606-613.
25. Spitzer R.L., Kroenke K., Williams J.B. Validation and utility of a self-report version of PRIME-MD: the PHQ primary care study. Primary care evaluation of mental disorders. Patient health questionnaire. JAMA 1999, 282:1737-1744.
26. Faller H., Stork S., Schowalter M., et al. Depression and survival in chronic heart failure: does gender play a role?. Eur J Heart Fail 2007, 9:1018-1023.
27. Pressler S.J., Subramanian U., Perkins S.M., et al. Measuring depressive symptoms in heart failure: validity and reliability of the patient health questionnaire-8. Am J Crit Care 2011, 20:146-152.
28. Hoenig J.M., Heisey D.M. The abuse of power: the pervasive fallacy of power calculations for data analysis. Am Stat 2001, 55:19-24.
29. Fava M., Davidson K.G. Definition and epidemiology of treatment-resistant depression. Psychiatr Clin North Am 1996, 19:179-200.
30. Rieckmann N., Gerin W., Kronish I.M., et al. Course of depressive symptoms and medication adherence after acute coronary syndromes: an electronic medication monitoring study. J Am Coll Cardiol 2006, 48:2218-2222.
31. Rieckmann N., Kronish I.M., Haas D., et al. Persistent depressive symptoms lower aspirin adherence after acute coronary syndromes. Am Heart J 2006, 152:922-927.
32. Kronish I.M., Rieckmann N., Halm E.A., et al. Persistent depression affects adherence to secondary prevention behaviors after acute coronary syndromes. J Gen Intern Med 2006, 21:1178-1183.
33. Gary R.A., Dunbar S.B., Higgins M.K., Musselman D.L., Smith A.L. Combined exercise and cognitive behavioral therapy improves outcomes in patients with heart failure. J Psychosom Res 2010, 69:119-131.
34. Kostis J.B., Rosen R.C., Cosgrove N.M., Shindler D.M., Wilson A.C. Nonpharmacologic therapy improves functional and emotional status in congestive heart failure. Chest 1994, 106:996-1001.
35. Sullivan M.J., Wood L., Terry J., et al. The support, education, and research in chronic heart failure study (search): a mindfulness-based psychoeducational intervention improves depression and clinical symptoms in patients with chronic heart failure. Am Heart J 2009, 157:84-90.
36. Turvey C.L., Klein D.M., Pies C.J. Depression, physical impairment, and treatment of depression in chronic heart failure. J Cardiovasc Nurs 2006, 21:178-185.
37. Guck T.P., Elsasser G.N., Kavan M.G., Barone E.J. Depression and congestive heart failure. Congest Heart Fail 2003, 9:163-169.
38. Jiang W., Krishnan R., Kuchibhatla M., et al. Characteristics of depression remission and its relation with cardiovascular outcome among patients with chronic heart failure (from the SADHART-CHF study). Am J Cardiol 2011, 107:545-551.
39. Glassman A.H., Johnson L.L., Giardina E.G., et al. The use of imipramine in depressed patients with congestive heart failure. JAMA 1983, 250:1997-2001.